In the following, only factors affecting AA availability will be described
Sources and further reading on semaglutide, PCOS, and the menstrual cycle Guidance draws on peer-reviewed GLP-1 receptor agonist trials in PCOS, mechanism research, regulatory documents, and patient-facing summaries from leading medical bodies
Many patients do not report their side effects through official systems, either because they are unaware of them or because reporting is too complicated
Symptom journal: Brief daily notes about pain, diet limits, or missed workdays can strengthen credibility when paired with provider notes
To put them in context, a person weighing 100 kg who adhered fully to treatment would, on average, lose approximately 16.6 kg over 64 weeks
Signs include dark urine, decreased urination frequency, dizziness upon standing, and dry mucous membranes